Ali Pourvali

Dr. Ali Pourvali


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
ZKZahra Kanannejad
Zahra Kanannejad
APAli Pourvali
Ali Pourvali
HEHossein Esmaeilzadeh
Hossein Esmaeilzadeh
RSRaheleh Shokouhi Shoormasti
Raheleh Shokouhi Shoormasti
MFMohammad Reza Fazlollahi
Mohammad Reza Fazlollahi
FZFatemeh Zaremehrjardi
Fatemeh Zaremehrjardi

20 May 2022 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
MMMana Momenilandi
Mana Momenilandi
APAli Pourvali
Ali Pourvali
ICInborn Errors of Immunity Consortium
Inborn Errors of Immunity Consortium
LMLeen Moens
Leen Moens
NPNima Parvaneh
Nima Parvaneh
XBXavier Bossuyt
Xavier Bossuyt

31 May 2023 in Journal of Asthma
Verified
Journal Article
Closed access
TETina Eslambeik
Tina Eslambeik
APAli Pourvali
Ali Pourvali
YGYazdan Ghandi
Yazdan Ghandi
AAAnita Alaghmand
Anita Alaghmand
MZMaryam Zamanian
Maryam Zamanian
Amin TajerianAmin Tajerian
Amin Tajerian
Asthma is a chronic condition characterized by episodic wheezing, cough, and shortness of breath resulting from airway hyperresponsiveness and inflammation. Over 300 million people are affected wor...

6 December 2023 in Journal of Asthma
Verified
Journal Article
Closed access
MSMahdi Sheykhi
Mahdi Sheykhi
APAli Pourvali
Ali Pourvali
YGYazdan Ghandi
Yazdan Ghandi
AAAnita Alaghmand
Anita Alaghmand
MZMaryam Zamanian
Maryam Zamanian
Amin TajerianAmin Tajerian
Amin Tajerian
Background: Asthma is a global health concern, especially among children, and is associated with various underlying mechanisms. Childhood exposure to early life stress and anxiety can potentially exacerbate asthma symptoms and complicate its management. While some studies have suggested the benefits of psychological therapies as adjuncts to medication in asthma management, evidence remains inconsistent, emphasizing the need for rigorous evaluation.Method: This case-control study involved 120 children aged 5-15, with 60 children having asthma and 60 healthy controls. Asthma severity was assessed based on EPR3 guidelines, while anxiety symptoms were measured using the Spence Children's Anxiety Scale (SCAS). Demographic data and asthma-related information were collected via questionnaires. Statistical analyses were conducted to explore the relationship between asthma and anxiety.Results: Children with asthma exhibited significantly higher anxiety symptoms compared to those without asthma (p < 0.001). Subdomain analysis revealed elevated scores in separation anxiety (SA; p = 0.025), social phobia (SP; p < 0.001), agoraphobia (p = 0.004), and fears of physical injury (p < 0.001) in children with asthma. Furthermore, increased need for SABA, frequency of nocturnal symptoms, and asthma severity were associated with higher anxiety levels in pediatric asthma patients.Conclusions: This study highlights a significant association between asthma and heightened anxiety symptoms in children, particularly in domains, such as SA, SP, agoraphobia, and fears related to physical injury. However, limitations include reliance on self-evaluation questionnaires and the observational nature of the study, emphasizing the need for cautious interpretation.

5 June 2024 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Closed access
Amin TajerianAmin Tajerian
Amin Tajerian
APAli Pourvali
Ali Pourvali
MMMasoud Movahedi
Masoud Movahedi
MMMaryam Mohammadi
Maryam Mohammadi
BKBehzad Khansarinejad
Behzad Khansarinejad
MDMohammad Ali Daneshmand
Mohammad Ali Daneshmand
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a complex and potentially fatal hypersensitivity condition. We present a unique case report and literature review focusing on DRESS syndrome-associated myocarditis resulting from reactivated viral infections in a 21-year-old female. 3 weeks after 5-day oral co-trimoxazole consumption due to acne, she developed symptoms consistent with DRESS syndrome, including a generalized maculopapular rash. Despite prednisolone treatment, the patient developed fatal fulminant myocarditis linked to HHV-6 and CMV reactivation. The patient's death highlights the importance of early recognition and careful management of DRESS syndrome, especially considering the potential viral reactivation that can lead to severe complications. Postmortem investigations revealed that viral reactivation caused myocarditis. Careful consideration must be given to corticosteroid usage in DRESS treatment, as inappropriate prescribing may promote viral reactivation and subsequent complications. While high-dose corticosteroids initiated within the first week effectively suppress HHV-6 reactivation. Conversely, low-dose or late-start high-dose corticosteroids prove ineffective in preventing HHV-6 viremia. Late- onset or low- dose corticosteroids may lead to fatal complications following the primary viral reactivation.

7 November 2024 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
RORoghaye Ostadi
Roghaye Ostadi
APAli Pourvali
Ali Pourvali
Amin TajerianAmin Tajerian
Amin Tajerian
SASaeed Alinezhad
Saeed Alinezhad
ALAsghar Lotfi
Asghar Lotfi
JJJavad Javaheri
Javad Javaheri
Infantile Colic (IC) poses a significant challenge for parents as it manifests through repeated and extended episodes of fussiness, crying, or irritability occurring before the age of 5 months. The precise cause of IC is currently unknown. The association between IC, a family history of atopy, and the development of individual atopy in the future remains uncertain, given conflicting findings from prior studies. This study aimed to investigate the impact of parental atopy on IC severity and the effectiveness of the mother’s hypoallergenic Dairy-Free Diet in alleviating pain in infants with colic. This non-randomized trial conducted at Amirkabir Hospital in Arak, Iran, from January 2023 to October 2023, involving 206 eligible IC patients non-randomly assigned to two groups based on parental atopy history. Breastfed infants were prescribed a dairy-free diet, involving the removal of dairy products from the mother’s diet. Pain severity was assessed using the FLACC scale at baseline and after one-month of intervention. The research initially involved 206 subjects with an average age of 28.77 ± 9.99 days, evenly distributed based on parental atopy history. However, there was a 28.6% loss to follow-up, resulting in a final analyzed population of 147 individuals. The intervention, a maternal dairy-free diet, demonstrated a significant reduction in pain symptoms within both groups and overall (P = 0.001), with no significant difference in efficacy between infants with and without parental atopy history (P = 0.219). Parental history of atopy did not exhibit a significant association with colic pain severity (P = 0.404). The study revealed that the impact of the diet on colic severity varied, with more pronounced effects observed in cases of severe and moderate colic compared to mild cases. Adopting a Dairy-Free Diet significantly reduced colic symptoms, irrespective of parental atopy history. The severity of colic appears unrelated to parental atopy, and the observed improvement with a Dairy-Free diet is potentially attributed to milk intolerance rather than milk allergy.